KemPharm
Why Robinhood?
You can watch KemPharm and buy or sell other stocks, ETFs, and their options commission-free!About KMPH
Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia.
KMPH Key Statistics
Stock Snapshot
As of today, KemPharm(KMPH) shares are valued at $8.81. The company's market cap stands at 500.89M, with a P/E ratio of 6.68.
On 2026-03-14, KemPharm(KMPH) stock opened at —, reached a high of —, and a low of —.
The KemPharm(KMPH)'s current trading volume is 0, compared to an average daily volume of 2.17M.
During the past year, KemPharm(KMPH) stock moved between $6.19 at its lowest and $13.16 at its peak.
During the past year, KemPharm(KMPH) stock moved between $6.19 at its lowest and $13.16 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.